Littlepage Booth

Your Personal Legal Team For Drug Litigation

Headquartered in Houston , Texas, Littlepage Booth is a joint venture partnership between The Littlepage Firm and Rainey C. Booth, P.A. Littlepage Booth focuses exclusively on defective drug and medical device cases and currently represents thousands of people throughout the country who have been injured by prescription drugs such as Prempro, Avandia, Zithromax, Viagra, Propulsid, Zicam and Cox 2 Inhibitors such as Vioxx or Bextra. Further, the law firm has a leadership role in several litigations. Zoe Littlepage and Rainey Booth began working together in October 2000 and formed the joint venture in 2001. They have established themselves as one of the most dynamic trial teams in the country, cultivating a well-earned reputation for their aggressive, compelling courtroom style.

Vytorin

Vytorin is a combination drug made up of the compounds simvastatin and ezetimibe that's designed to reduce levels of LDL (bad) cholesterol and cut the risk of cardiovascular problems. It works by decreasing the production of cholesterol by the liver and inhibiting the absorption of cholesterol in the intestine.

U.S. drug regulators are investigating whether the cholesterol-lowering drug Vytorin might be linked to cancer.

The U.S. Food and Drug Administration said it has informed health-care professionals that the agency was investigating a report from the so-called Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial of a possible association between the use of Vytorin and an increased risk of a variety of cancers. The FDA said it had obtained preliminary results from the SEAS trial. The trial tested whether lowering LDL-cholesterol with Vytorin would reduce the risk of cardiovascular problems in people with narrowing of the aorta, the body's largest artery. The five-year trial did not show a reduced cardiovascular risk. But, a "larger percentage of patients treated with Vytorin were diagnosed with and died from all types of cancer combined, when compared to treatment with a placebo," the statement said.

If you are a loved one have taken Vytorin and developed cancer please contact April Cowgill at April@littlepagebooth.com

Rezulin

From 2000 to 2004, Zoe Littlepage and Rainey Booth led the Rezulin state court litigation, taking more than 100 days of depositions of Pfizer’s corporate representatives and reviewing millions of pages of internal documents. Littlepage Booth took six Rezulin case to trial gaining million of dollars in verdicts and have resolved tens of millions of dollars of Rezulin cases through jury awards and settlements.

Prempro

In 2003, federal judge William Wilson named Zoe Littlepage as lead counsel for all personal injury claims in the Prempro hormone replacement therapy litigation. While Ms. Littlepage heads the Plaintiff's Multi-District Litigation (MDL) Steering Committee, Mr. Booth co-chairs the Prempro MDL Science and Research Committee. These Committees represent the almost 8,000 women nationwide who assert that hormone therapy caused them to develop breast cancer. Zoe Littlepage and Rainey Booth were actively involved in 5 of the 9 Prempro cases that have advanced to trial to date and have secured either jury verdicts or settlements in every case but one. In 2006, Littlepage Booth tried the Daniel case in Philadelphia, PA where a jury returned a verdict of $1.5 million in compensatory damages as well as awarded additional money for punitive damages on behalf of Mary and Tom Daniel. In 2007, Zoe Littlepage and Rainey Booth won a case in Reno, Nevada where the jury again sided with three women who developed breast cancer from their use of hormone replacement therapy. The Reno trial court entered a verdict of more than $7 million for each woman in past and future compensatory damages as well as between $10 and $12 million for each woman in punitive damages. The success of Littlepage Booth in the hormone therapy litigation parallels the success seen with other trials around the country where juries have returned verdicts for the breast cancer victims of $2.7 million in compensatory damages and $27 million in punitive damages in a 2008 Little Rock, AR trial as well as $3 million and $1.5 million in compensatory damages in Philadelphia, PA trials.

Viagra

In 2006, the federal MDL judge in charge of all Viagra blindness cases appointed Zoe Littlepage to the Plaintiff’s Steering Committee to represent all litigants before the Court